Drugs / CI-1012
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002218 | — | HIV infectious disease | Parke-Davis | Completed | No outcome recorded |
| Phase 1 | NCT00002196 | — | HIV infectious disease | Parke-Davis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CI-1012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002218 ↗ |
| Route | Oral | “oral CI-1012 therapy” NCT00002196 ↗ |